Abstract
Pseudo-nephropathy and hyper-excretion of urinary C-peptide: an overlooked adverse effect of an angiotensin receptor–neprilysin inhibitor (ARNI)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have